Mark L Lang
Overview
Explore the profile of Mark L Lang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
652
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Norman K, Lang G, Shadid T, Honold S, Reel J, Cox M, et al.
Cell Rep
. 2024 May;
43(5):114245.
PMID: 38761377
Recurrent Clostridioides difficile infection (CDI) results in significant morbidity and mortality. We previously established that CDI in mice does not protect against reinfection and is associated with poor pathogen-specific B...
2.
Ray A, Saunders A, Nofchissey R, Reidy M, Kamal M, Lerner M, et al.
Clin Cancer Res
. 2023 Mar;
29(11):2158-2169.
PMID: 36951682
Purpose: G-CSF enhances colon cancer development. This study defines the prevalence and effects of increased G-CSF signaling in human colon cancers and investigates G-CSF inhibition as an immunotherapeutic strategy against...
3.
Gunay G, Hamsici S, Lang G, Lang M, Kovats S, Acar H
Adv Sci (Weinh)
. 2022 May;
9(21):e2105868.
PMID: 35599386
Immunogenic cell death (ICD) arises when cells are under stress, and their membranes are damaged. They release damage-associated molecular patterns (DAMPs) that stimulate and drive the type and magnitude of...
4.
Song C, Li Z, Ahmed U, Bland S, Yashchenko A, Liu S, et al.
J Am Soc Nephrol
. 2022 Feb;
33(4):747-768.
PMID: 35110364
Background: Inducible disruption of cilia-related genes in adult mice results in slowly progressive cystic disease, which can be greatly accelerated by renal injury. Methods: To identify in an unbiased manner...
5.
Lang G, Norman K, Amadou Amani S, Shadid T, Ballard J, Lang M
Front Immunol
. 2022 Jan;
12:818734.
PMID: 35095921
Adjuvant combinations may enhance or broaden the expression of immune responses to vaccine antigens. Information on whether established Alum type adjuvants can be combined with experimental CD1d ligand adjuvants is...
6.
Liu K, Hoover A, Krawic J, DeVette C, Sun X, Hildebrand W, et al.
Theranostics
. 2022 Jan;
12(2):639-656.
PMID: 34976205
B cells have emerged as key regulators in protective cancer immunity. However, the activation pathways induced in B cells during effective immunotherapy are not well understood. We used a novel...
7.
8.
Larcade R, DeShea L, Lang G, Caballero M, Ferretti A, Beasley W, et al.
J Infect Dis
. 2021 Dec;
225(5):800-809.
PMID: 34865064
Background: Coronavirus disease 2019 (COVID-19) disproportionally affects pregnant women and their newborn; however, little is known about variables that modulate maternal-fetal immune response to infection. Methods: We prospectively studied socioeconomic,...
9.
Lang G, Shrestha B, Amadou Amani S, Shadid T, Ballard J, Lang M
Infect Immun
. 2021 Aug;
89(11):e0043821.
PMID: 34424751
All clinical Clostridioides difficile strains identified to date express a surface capsule-like polysaccharide structure known as polysaccharide II (PSII). The PSII antigen is immunogenic and, when conjugated to a protein...
10.
Amadou Amani S, Lang G, Ballard J, Lang M
Infect Immun
. 2021 Jun;
89(10):e0027421.
PMID: 34097471
The pathology associated with Clostridioides difficile disease is caused in large part by TcdB, an intracellular bacterial toxin that inactivates small GTPases. Despite C. difficile causing enteric disease, antitoxin IgG...